Dublin, Ireland-based Research & Markets has added the following reports to its offering:
- World Generic Markets - containing up-to-date information on the latest developments in the generics sector, including the changing role of generics as the number of highly lucrative drugs lose their patent protection increases;
- PharmaVitae 2004: Eli Lilly Global & US Analysis - which examines US drug giant Eli Lilly's market position and future outlook, with details on global and US specific business strategy, portfolio and pipeline analysis and assessment of financial performance with key projections to 2010; and
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze